Ingredient Guide  ·  Skincare Science

Bakuchiol vs Retinol: The Gentler Alternative, Explained

Bakuchiol has moved from niche botanical curiosity to one of the most searched-for skincare ingredients in the world. Some of that is deserved. Some is marketing. This guide works through the actual science, where it holds up, where it does not, and how it compares to retinol on evidence rather than hype.

01What is bakuchiol?

Bakuchiol (pronounced buh-KOO-chee-ol) is a meroterpene phenol extracted from the seeds and leaves of Psoralea corylifolia, a plant with roots in traditional Ayurvedic and Chinese medicine where it goes by the name "babchi."¹ The purified cosmetic compound was first characterized for skin use in the early 2000s, with the main breakthrough paper arriving in 2014 when gene expression profiling revealed that bakuchiol regulates skin cell behavior in ways that overlap meaningfully with retinol, despite having no structural resemblance to it whatsoever.²

That last point is worth sitting with. "Natural retinol" is a marketing phrase, not a pharmacological description. Retinol is a diterpenoid alcohol that directly binds nuclear retinoic acid receptors (RAR-alpha, -beta, -gamma). Bakuchiol is a meroterpene phenol that does not bind those receptors at all.³ What they share is an outcome, not a mechanism: both can support collagen gene expression and produce visible improvements in fine lines and pigmentation. How they get there is different, and that distinction matters for understanding who should use which one.

One important quality note: pure bakuchiol is not the same as crude babchi oil or whole seed extract of Psoralea corylifolia. The whole plant extract contains psoralens, furanocoumarins that increase UV sensitivity. Pure bakuchiol does not.⁴ When evaluating a product, look for "bakuchiol" listed as the ingredient, not "babchi oil" or "Psoralea corylifolia seed oil." A reputable formulator will specify the compound and, ideally, a disclosed concentration.

02How bakuchiol works on skin

The 2014 Chaudhuri and Bojanowski paper in the International Journal of Cosmetic Science is the foundational mechanism study. They used gene expression profiling on a full-thickness skin substitute model and found bakuchiol upregulates types I, III, and IV collagen, aquaporin 3 (a water-channel protein), and lipid-binding CRBP transport proteins, all endpoints that retinol also hits. The difference: retinol upregulates RAR-beta and RAR-gamma (the receptors responsible for its irritation cascade) while bakuchiol does not.² This mechanistic gap explains the tolerability advantage that shows up consistently in clinical testing.

Collagen and extracellular matrix support

Multiple in vitro studies confirm bakuchiol supports fibroblast production of collagen types I, III, and IV, as well as fibronectin. A 2022 Beiersdorf study found bakuchiol both enhanced collagen expression and uniquely stimulated fibroblast growth factor 7 (FGF-7), a wound-healing signal that retinol does not trigger.⁵ It also inhibits matrix metalloproteinases (MMPs), the enzymes responsible for breaking down existing collagen, which complements its production-boosting activity.

Antioxidant activity

Bakuchiol's antioxidant capacity is genuinely impressive in vitro. The same 2022 Beiersdorf study measured DPPH radical scavenging capacity at 12,125 AU for bakuchiol versus 848 AU for retinol, roughly a 14-fold difference.⁵ Antioxidant activity helps explain part of bakuchiol's photoaging-related benefits and its appeal for pollution-exposed skin. The in vitro numbers are striking but should not be over-extrapolated to guaranteed clinical superiority; skin absorption and bioavailability complicate direct translation.

Anti-inflammatory signaling

Bakuchiol reduces prostaglandin E2 (PGE2) and macrophage migration inhibitory factor (MIF), two inflammation mediators relevant to chronic skin aging and acne. It suppresses IL-8 expression from UVA exposure in dermal fibroblasts by 88.3% in one in vitro study,⁶ and inhibits the p38 MAPK/ERK signaling pathway, a separate anti-inflammatory mechanism. For acne-related concerns, its antibacterial activity against Propionibacterium acnes (now called Cutibacterium acnes) via cell membrane disruption adds another relevant pathway.⁷

Cell turnover: the key difference from retinol

Retinol drives keratinocyte proliferation. This is the source of its most visible short-term effect (accelerated cell turnover, faster surface renewal) and also its most common problem (the dryness, peeling, and irritation of "retinization"). Bakuchiol produces collagen gene upregulation without promoting cell proliferation.⁸ The surface renewal mechanism is slower and less aggressive. If you want rapid visible exfoliation, retinol delivers it; if you need the same endpoint without the aggression, bakuchiol takes a longer, calmer route.

03The clinical evidence, honestly assessed

This is where it is worth being direct: bakuchiol's clinical evidence base is thinner than its marketing suggests, and thinner than retinol's. The most comprehensive independent assessment came in 2024, when a systematic review in the Journal of Drugs in Dermatology examined every available human clinical trial through August 2022. Of the 15 trials identified: 12 of 15 were unblinded, open-label, and had no control group. Ten of 15 used combination therapies, not bakuchiol alone. Four trials failed to specify the concentration used. The authors concluded that "trials lack methodologic rigor, which introduces a high risk of bias in reported outcomes."⁹

That does not make bakuchiol ineffective. It means the clinical signal is real but the proof is weaker than it should be for something so widely sold. Here is what the better studies actually show:

The Dhaliwal 2019 head-to-head RCT

This is the headline study and the only randomized, double-blind trial comparing bakuchiol directly to retinol. Published in the British Journal of Dermatology, it enrolled 44 participants, assigned them to 0.5% bakuchiol cream twice daily or 0.5% retinol cream once daily for 12 weeks. Both groups showed statistically significant reductions in wrinkle surface area and hyperpigmentation, with no statistically significant difference between the two compounds. Retinol users reported significantly more facial scaling and stinging.¹⁰

The limitations are real and worth naming: 44 participants is underpowered. The "blinding" was imperfect because retinol was applied once daily and bakuchiol twice daily, which experienced participants could likely detect. A critical commentary published in 2020 noted the absence of a vehicle/placebo control, meaning moisturization alone might account for some improvement.¹¹ The authors of the bakuchiol research responded, defending methodology and expanding on assessment techniques.¹² The debate illustrates where bakuchiol sits: plausible, promising, not proven at the level of pharmaceutical-standard evidence.

Post-inflammatory hyperpigmentation (PIH)

The PIH evidence is arguably bakuchiol's strongest case. A 2024 systematic review in the Journal of the American Academy of Dermatology reviewed nine studies and found seven of nine reported statistically significant improvement in PIH with bakuchiol.¹³ The authors noted it looks particularly useful for Fitzpatrick skin types III to VI, the skin tones where retinoid-triggered irritation and post-inflammatory hyperpigmentation are harder to manage, making a gentle alternative especially relevant.

Acne and sebum

Several studies support bakuchiol's role in acne management. A 2015 randomized controlled trial found that adding a bakuchiol-containing complex to adapalene 0.1% gel produced significantly greater reductions in inflammatory lesions (62.7%) compared to adapalene plus vehicle (41.5%).⁷ The antibacterial and sebum-regulating properties observed in vitro appear to translate to some clinical benefit, though most acne trials used bakuchiol as an add-on, not a standalone therapy.

Industry funding is a legitimate concern

A meaningful portion of the bakuchiol literature has conflicts of interest worth noting. The foundational 2014 gene expression paper was authored by the founder of Sytheon, the company that manufactures Sytenol A (the purified bakuchiol ingredient). Several subsequent clinical studies come from authors employed by cosmetic companies who commercialize bakuchiol formulations. The independent trials, including Dhaliwal 2019 and Fanning 2024, show more measured results than industry-funded studies. Reading the funding disclosures before weighing a study's conclusions is genuinely worthwhile here.

04Bakuchiol vs retinol: a property-by-property comparison

Rather than a competitive product table, this is an ingredient-level comparison across the properties that matter most for choosing between them. No formulation values here, just the compounds themselves.

The table makes the choice fairly clear for most scenarios. Retinol is the better-evidenced anti-aging active for people who can tolerate it. Bakuchiol is a genuinely useful alternative for those who cannot, and it has its own distinct strengths in antioxidant activity and PIH management. They are not interchangeable on the evidence, but they are both defensible choices depending on your skin's specific needs and history. See our comparison of copper peptides vs retinol if you want to add a third active to that framework.

05Who bakuchiol actually suits

Most ingredient guides either oversell or undersell. Bakuchiol is worth being precise about, because it genuinely helps specific people and is probably unnecessary for others.

Bakuchiol is a strong candidate if:

• You have tried retinol and found the irritation, dryness, or initial purging phase intolerable, even at lower concentrations
• You have rosacea, perioral dermatitis, or eczema: these conditions are aggravated by retinol's keratinocyte proliferation and bakuchiol's non-RAR pathway sidesteps that trigger entirely
• You are building a first active routine and want something with a meaningful mechanism and very low barrier to consistent use
• You have darker skin tones (Fitzpatrick III to VI) where retinoid-triggered irritation creates its own PIH risk, partially defeating the purpose¹³
• You want to address acne-related hyperpigmentation alongside active breakouts, where bakuchiol's anti-inflammatory and antibacterial properties work together
• You are pregnant or nursing and have discussed topical actives with your healthcare provider (bakuchiol lacks retinol's teratogenic mechanism, though dedicated human pregnancy safety data is absent)

Retinol is likely the better choice if:

• Your primary goal is visible anti-aging results and you have no tolerability issues with retinol, because the evidence base is simply larger and more rigorous
• You want the fastest possible surface texture improvement, since retinol's keratinocyte turnover effect produces it more quickly
• You are already tolerating a retinol product well, in which case adding bakuchiol offers marginal benefit over optimizing what you have

There is also a third path worth naming: using both. There is no known antagonism between bakuchiol and retinol, and one 2023 open-label trial found combining retinal with bakuchiol enhanced effects on keratinocyte differentiation genes beyond what either achieved alone.¹⁴ Some people use retinol on nights when their skin is not reactive and bakuchiol on the others, maintaining a daily active habit without accumulating irritation. This is a reasonable approach for those building toward a fuller retinol routine.

06How to use bakuchiol

One of bakuchiol's practical advantages is flexibility. Because it is photostable and does not increase UV sensitivity, it can be used in the morning, the evening, or both. The Dhaliwal 2019 trial applied it twice daily throughout without accumulating adverse events, while retinol was restricted to once-daily nighttime use.¹⁰

Routine placement

Apply bakuchiol after cleansing and any water-based serums, before moisturizer. It is an oil-soluble compound, so it layers well under heavier emollients. Morning use: follow with SPF, as you would with any active. Evening use: bakuchiol is compatible with most other actives, including niacinamide, hyaluronic acid, and vitamin C. There is no known interaction with any common skincare ingredient that would require separation.

Pairing with other actives

• Niacinamide: highly compatible. Both address pigmentation and support the skin barrier through different pathways. No published clinical trial exists specifically on this combination, but no antagonism is reported either
• Vitamin C: compatible; both are antioxidants with complementary mechanisms, and bakuchiol's own antioxidant pathway (Nrf2 activation, ROS scavenging) complements vitamin C's direct radical neutralization¹⁵
• Retinol: compatible; use on alternating evenings if you want both without stacking irritation, or use bakuchiol in the morning and retinol at night
• Chemical exfoliants (AHAs/BHAs): bakuchiol is less irritating than retinol but combining multiple actives always warrants caution; introducing one at a time is the most reliable approach

What to expect over time

Bakuchiol's timeline is slower than retinol's precisely because it does not drive rapid keratinocyte turnover. A realistic expectation based on the clinical data: subtle improvements in texture and hydration in the first four weeks, more visible changes in fine lines and uneven tone between weeks eight and twelve, with cumulative benefits continuing beyond that with consistent use.¹⁶ There is no purging phase to navigate, which means you do not have to build tolerance gradually the way you do with retinol.

07On retinol: an honest note

Retinol remains the best-supported over-the-counter anti-aging ingredient. It has more rigorous trials, larger study populations, longer follow-up periods, and a clearer mechanistic understanding than any cosmetic alternative, including bakuchiol. A 52-week double-blind vehicle-controlled trial found 0.1% stabilized retinol produced a 44% improvement in crow's feet and an 84% improvement in mottled pigmentation.¹⁷ A 2024 systematic review in the American Journal of Clinical Dermatology examining 25 studies concluded that while alternative topical treatments showed comparable tolerability, "tretinoin remains the gold standard with alternatives serving patients who cannot tolerate it."¹⁸

MAXXING formulates Smooth Criminal around retinol because the evidence supports it as the primary active for those working on skin texture, fine lines, and long-term surface renewal. If your skin tolerates retinol, a well-formulated retinol serum is likely to produce larger visible improvements over a 12-week period than bakuchiol alone. For deeper context on what the molecule actually does, the guide on what retinol does for skin covers the mechanism in full. For a broader multi-active framework, the looksmaxxing skincare routine guide explains how to sequence these ingredients alongside copper peptides and other actives.

The honest framing: bakuchiol is not a replacement for retinol. It is an alternative for people who need one, and a complementary active for those who want to layer both. Knowing which camp you are in saves money and gets better results than buying based on marketing copy.

Frequently asked questions